SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Hargreaves Lansdown plc (HRGLY) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 74/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — HRGLY
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2014 |
$0.68 |
$358.39M |
$162.09M |
45.2% |
| 2015 |
$0.66 |
$395.14M |
$156.66M |
39.6% |
| 2016 |
$0.75 |
$388.33M |
$176.9M |
45.6% |
| 2017 |
$0.89 |
$385.7M |
$211.7M |
54.9% |
| 2018 |
$0.99 |
$447.6M |
$236.3M |
52.8% |
| 2019 |
$1.04 |
$480.5M |
$247.4M |
51.5% |
| 2020 |
$1.32 |
$550.9M |
$313.1M |
56.8% |
| 2021 |
$1.25 |
$631M |
$296.7M |
47% |
| 2022 |
$0.91 |
$583M |
$216.3M |
37.1% |
| 2023 |
$0.00 |
$735.1M |
$323.8M |
44% |
